business

Citizens raises Abivax stock price target on ulcerative colitis drug data

Investing.com · Jun 2, 2026, 8:51 AM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

STAT News STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns Bloomberg Tech STMicro Raises Estimates for Data Center Revenue to $1 Billion Yahoo Finance Jim Cramer Discusses the Analyst Price Target Cut for Ulta Beauty

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Citizens raises Abivax stock price target on ulcerative colitis drug data

Also covered by

More in business